Investor Presentaiton slide image

Investor Presentaiton

Sartorius Group Bioprocess Solutions (BPS): solution provider for biomanufacturing € ~€2.68bn Sales revenue 2023 ☺ 29.2% EBITDA margin ¹ 2023 ~75% Recurring revenues ~90% Sales share biopharma 1 Excluding extraordinary items 16 16 M Filtration SARTORIUS SPRE Purification Fermentation Fluid management SARTORIUS
View entire presentation